Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CNX Resources CorpCNX · Entity 3842 | Director | May 09, 2017 | May 11, 2017 |
| Core Natural Resources, Inc.CEIX · Entity 3899 | Director | May 03, 2022 | May 05, 2022 |
| Protea Biosciences Group, Inc.PRGB · Entity 177226 | Director | March 24, 2017 | April 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CNX Resources Corp
Report date May 09, 2017 · Filed May 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares, $0.01 par value per shareSEC Table I · non-derivative | Direct | 15,647 |
Reported balance
After 2017-05-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-09 · Grant · Acquired 12,716 · Balance 15,647 F1: Of the 15,647 shares owned directly, 6,086 are deferred stock units and 9,561 are restricted stock units (including dividend equivalent rights). |
Filing footnotes · ownership attribution and instrument terms
F1: Of the 15,647 shares owned directly, 6,086 are deferred stock units and 9,561 are restricted stock units (including dividend equivalent rights).
Core Natural Resources, Inc.
Report date May 03, 2022 · Filed May 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 74,727 |
Reported balance
After 2022-05-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-03 · Grant · Acquired 3,062 · Balance 74,727 F1: Represents a grant of 3,062 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 3, 2023. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person has elected to defer delivery of the vested shares until his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. |
| Common stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 75,951 |
Reported balance
After 2022-05-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-05-03 · Grant · Acquired 1,224 · Balance 75,951 F2: Represents director compensation for which the Reporting Person has elected to defer delivery until the second anniversary of the date of his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. F3: Of the 75,951 shares reported, 3,062 are unvested restricted stock units (including dividend equivalent rights) and 39,224 are vested deferred stock units (including dividend equivalent rights). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of 3,062 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 3, 2023. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person has elected to defer delivery of the vested shares until his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors.
F2: Represents director compensation for which the Reporting Person has elected to defer delivery until the second anniversary of the date of his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors.
F3: Of the 75,951 shares reported, 3,062 are unvested restricted stock units (including dividend equivalent rights) and 39,224 are vested deferred stock units (including dividend equivalent rights).
Protea Biosciences Group, Inc.
Report date March 24, 2017 · Filed April 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,005,456 |
Reported balance
After 2017-03-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-03-24 · Other · Acquired 400,000 · Balance 1,005,456 F1: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F3: Includes 67,856 shares of Common Stock owned of record by Raymond James & Associates, Inc., an IRA account of Ed Roberson. |
| Class A Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2018-09-24 | Direct | 1,123,927 |
Reported balance
After 2017-03-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-03-24 · Other · Acquired 400,000 · Balance 1,123,927 F1: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F4: Includes 857,260 shares of Common Stock to be acquired upon the exercise of warrants and 266,667 shares of Common Stock to be acquired upon the exercise of stock options. |
| Class B Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.11 · Expires 2022-03-24 | Direct | 1,123,927 |
Reported balance
After 2017-03-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-03-24 · Other · Acquired 400,000 · Balance 1,123,927 F1: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F4: Includes 857,260 shares of Common Stock to be acquired upon the exercise of warrants and 266,667 shares of Common Stock to be acquired upon the exercise of stock options. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant").
F2: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant.
F3: Includes 67,856 shares of Common Stock owned of record by Raymond James & Associates, Inc., an IRA account of Ed Roberson.
F4: Includes 857,260 shares of Common Stock to be acquired upon the exercise of warrants and 266,667 shares of Common Stock to be acquired upon the exercise of stock options.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2022 Filed May 5, 2022 20:35 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 1,224 | $48.98 | $59,951.52 |
DisclosureSEC source: 0000899243-22-017001 · doc4.xml · nonDerivative · entry 2 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,951 F2 · shares: Represents director compensation for which the Reporting Person has elected to defer delivery until the second anniversary of the date of his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. F3 · balance_after: Of the 75,951 shares reported, 3,062 are unvested restricted stock units (including dividend equivalent rights) and 39,224 are vested deferred stock units (including dividend equivalent rights). Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:35 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 3,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017001 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,727 F1 · shares: Represents a grant of 3,062 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 3, 2023. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person has elected to defer delivery of the vested shares until his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:51 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 5,671 | $10.58 | $59,999.18 |
DisclosureSEC source: 0000899243-21-018509 · doc4.xml · nonDerivative · entry 2 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,665 F2 · shares: Represents director compensation for which the Reporting Person has elected to defer delivery until the second anniversary of the date of his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. F3 · balance_after: Of the 71,665 shares reported, 34,419 are unvested restricted stock units (including dividend equivalent rights) and 25,047 are vested deferred stock units (including dividend equivalent rights). Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:51 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 14,177 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018509 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,994 F1 · shares: Represents a grant of 14,177 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 4, 2022. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person has elected to defer delivery of the vested shares until the second anniversary of the date of his separation of service from the Issuer under the Issuer's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 19:36 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | OtherCommon stock, par value $0.01 per share | 4,745 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000204 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,817 F1 · shares: As part of the Issuer's acquisition of the remaining common units representing limited partner interests of CONSOL Coal Resources LP ("CCR") on December 30, 2020, each common unit of CCR previously held by the reporting person has converted into the right to receive 0.73 shares of common stock, par value $0.01 per share, of the Issuer. F1 · price: As part of the Issuer's acquisition of the remaining common units representing limited partner interests of CONSOL Coal Resources LP ("CCR") on December 30, 2020, each common unit of CCR previously held by the reporting person has converted into the right to receive 0.73 shares of common stock, par value $0.01 per share, of the Issuer. F2 · balance_after: Of the 51,817 shares reported as directly held, 20,242 are unvested restricted stock units (including dividend equivalent rights) and 19,376 are vested deferred stock units (including dividend equivalent rights). Read SEC document |
| May 11, 2020 Filed May 12, 2020 21:18 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 20,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012897 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,072 F1 · shares: Represents a grant of 20,242 restricted stock units pursuant to the Issuer's 2020 Amended and Restated Omnibus Performance Incentive Plan, all of which will vest on May 11, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Of the 47,072 shares reported, 20,242 are unvested restricted stock units (including dividend equivalent rights) and 19,376 are vested deferred stock units (including dividend equivalent rights). Read SEC document |
| May 08, 2019 Filed May 13, 2019 16:08 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 3,310 | $31.15 | $103,106.50 |
DisclosureSEC source: 0000899243-19-013207 · doc4.xml · nonDerivative · entry 2 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,830 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F3 · shares: Represents director compensation for which the Reporting Person has elected to defer delivery over a five-year period beginning on the fifth anniversary of the grant date under the Issuer's Deferred Compensation Plan for Non-Employee Directors. F4 · balance_after: Of the 26,830 shares reported, 4,815 are unvested restricted stock units (including dividend equivalent rights) and 14,561 are vested deferred stock units (including dividend equivalent rights). Read SEC document |
| May 08, 2019 Filed May 13, 2019 16:08 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 4,815 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013207 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,520 F1 · shares: Represents a grant of 4,815 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 8, 2020. The Reporting Person has elected to defer delivery of the vested shares over a five-year period beginning on the fifth anniversary of the grant date under the Issuer's Deferred Compensation Plan for Non-Employee Directors. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock Read SEC document |
| May 09, 2018 Filed May 11, 2018 17:50 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 3,491 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012572 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,705 F1 · shares: Represents a grant of 3,491 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on May 9, 2019. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The reporting person may elect to defer delivery of a portion of the vested shares until his separation of service from the Company. F2 · balance_after: Of the 18,705 shares reported, 6,844 are unvested restricted stock units (including dividend equivalent rights) and 11,251 are deferred stock units (including dividend equivalent rights). Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 16:53 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | PurchaseCommon stock, par value $0.01 per share | 610 | $33.01 | $20,134.88 |
DisclosureSEC source: 0000899243-18-005327 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,214 F1 · balance_after: Of the 15,214 shares reported, 10,227 are unvested restricted stock units (including dividend equivalent rights) and 4,377 are deferred stock units (including dividend equivalent rights). Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 20:28 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 3,353 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-028769 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,604 F1 · shares: Represents a grant of 3,353 restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, all of which will vest on December 12, 2018. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Of the 14,604 shares reported, 10,227 are unvested restricted stock units (including dividend equivalent rights) and 4,377 are deferred stock units (including dividend equivalent rights). Read SEC document |
| November 28, 2017 Filed Dec 14, 2017 18:20 UTC | Core Natural Resources, Inc. CEIX · Entity 3899 | GrantCommon stock, par value $0.01 per share | 11,251 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-028717 · doc4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,251 F1 · shares: Represents unvested restricted stock units and deferred stock units issued in accordance with the Employee Matters Agreement dated as of November 28, 2017 between the Issuer and CNX Resources Corporation (f/k/a CONSOL Energy Inc.) ("CNX") as a result of the conversion of the restricted stock units and deferred stock units held by the Reporting Person immediately before the legal and structural separation of the Issuer from CNX. F2 · balance_after: Of the 11,251 reported shares, (i) 6,874 are unvested restricted stock units (including dividend equivalent rights) which continue to be subject to their original CNX vesting schedule and for which the Reporting Person has elected to defer delivery of the underlying shares until his separation of service from the Issuer, and (ii) 4,377 are deferred stock units (including dividend equivalent rights) of which 2,269 of the underlying shares will be delivered upon the Reporting Person's separation of service from the Issuer and 2,108 of the underlying shares will be delivered on January 1, 2020. The unvested restricted stock units vest in full on May 9, 2018, which is the first anniversary of their original date of grant from CNX. Read SEC document |
| May 09, 2017 Filed May 11, 2017 20:41 UTC | CNX Resources Corp CNX · Entity 3842 | GrantCommon shares, $0.01 par value per share | 12,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001070412-17-000056 · wf-form4_149453524447537.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,647 F1 · balance_after: Of the 15,647 shares owned directly, 6,086 are deferred stock units and 9,561 are restricted stock units (including dividend equivalent rights). Read SEC document |
| March 24, 2017 Filed Apr 4, 2017 16:29 UTC | Protea Biosciences Group, Inc. PRGB · Entity 177226 | OtherClass B Warrant (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001144204-17-018882 · v463510_form4.xml · derivative · entry 3 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,927 Underlying: Common Stock · 400,000 shares Expires 2022-03-24 F1 · security: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F1 · derivative.exercise_price: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F1 · shares: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2 · shares: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F1 · derivative.underlying_shares: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2 · derivative.underlying_shares: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F4 · balance_after: Includes 857,260 shares of Common Stock to be acquired upon the exercise of warrants and 266,667 shares of Common Stock to be acquired upon the exercise of stock options. Read SEC document |
| March 24, 2017 Filed Apr 4, 2017 16:29 UTC | Protea Biosciences Group, Inc. PRGB · Entity 177226 | OtherClass A Warrant (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001144204-17-018882 · v463510_form4.xml · derivative · entry 2 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,927 Underlying: Common Stock · 400,000 shares Expires 2018-09-24 F1 · security: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F1 · derivative.exercise_price: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F1 · shares: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2 · shares: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F1 · derivative.underlying_shares: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F2 · derivative.underlying_shares: The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant. F4 · balance_after: Includes 857,260 shares of Common Stock to be acquired upon the exercise of warrants and 266,667 shares of Common Stock to be acquired upon the exercise of stock options. Read SEC document |
| March 24, 2017 Filed Apr 4, 2017 16:29 UTC | Protea Biosciences Group, Inc. PRGB · Entity 177226 | OtherCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018882 · v463510_form4.xml · nonDerivative · entry 1 ROBERSON ED · CIK 0001529381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,456 F1 · date: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F1 · shares: Mr. Roberson held $30,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Roberson exchanged $30,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 400,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock"), valued at $0.075 per share, (b) 18 month Class A warrants to purchase 400,000 shares of Common Stock at an exercise price of $0.09 per share ("Class A Warrant"), and (c) five year Class B warrants to purchase another 400,000 shares at an exercise price of $0.1125 per share ("Class B Warrant"). F3 · balance_after: Includes 67,856 shares of Common Stock owned of record by Raymond James & Associates, Inc., an IRA account of Ed Roberson. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.